Applying Modern Molecular Microbiological Techniques to Identify Treatable Chronic Bacterial Airway Infection in Severe Asthma

M. Jabeen (Oxford (Oxfordshire), United Kingdom), T. Street (Oxford (Oxfordshire), United Kingdom), D. Foster (Oxford (Oxfordshire), United Kingdom), D. Crook (Oxford (Oxfordshire), United Kingdom), N. Sanderson (Oxford (Oxfordshire), United Kingdom), I. Pavord (Oxford (Oxfordshire), United Kingdom), P. Klenerman (Oxford (Oxfordshire), United Kingdom), T. Hinks (Oxford (Oxfordshire), United Kingdom)

Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Session: Airway infection: the microbiome and beyond
Session type: Oral Presentation
Number: 4930
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Jabeen (Oxford (Oxfordshire), United Kingdom), T. Street (Oxford (Oxfordshire), United Kingdom), D. Foster (Oxford (Oxfordshire), United Kingdom), D. Crook (Oxford (Oxfordshire), United Kingdom), N. Sanderson (Oxford (Oxfordshire), United Kingdom), I. Pavord (Oxford (Oxfordshire), United Kingdom), P. Klenerman (Oxford (Oxfordshire), United Kingdom), T. Hinks (Oxford (Oxfordshire), United Kingdom). Applying Modern Molecular Microbiological Techniques to Identify Treatable Chronic Bacterial Airway Infection in Severe Asthma. 4930

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019


How to Manage Severe Asthma, the Value of Inflammation Monitoring
Source: Research Seminar 2007 - Severe Asthma
Year: 2007


Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019


Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019


Epidemiology and Triggers of Severe Asthma
Source: Research Seminar 2007 - Severe Asthma
Year: 2007


The Use of Respiratory Sounds for Automated Detection of Obstructive Pulmonary Disease: Do Lung Sound Labels Provide Value?
Source: International Congress 2017 – Lung function testing in different patient categories
Year: 2017

Non Invasive Ventilation in Acute Respiratory Failure in Patients of Post Tubercular Bronchiectasis: Effectiveness and Predictors of Failure.
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017

Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Aerobic Exercise Improves Asthma Phenotype in a Model of Severe Asthma: Involvement of Kinins
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021


Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017


Inflammatory Pathways and Mediators in the Pathogenesis of Severe Asthma
Source: Research Seminar 2007 - Severe Asthma
Year: 2007


Feasibility of Measuring Neural Respiratory Drive in the Home Following Severe COPD Exacerbation
Source: International Congress 2019 – New insights into respiratory function testing
Year: 2019



Effects of Thoracic Mobilization Techniques on Pulmonary Functions, Dyspnea and Health Status in Patients with Asthma
Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease
Year: 2019


The Frequency of Small Airway Dysfunction and Its Relationship with Disease Control in Chronic Airway Diseases
Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases
Year: 2021


Managing T2-High Inflammation in Severe Asthma - Are Biomarkers Better Than Clinician Judgement?
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020


Diagnosis of Endoscopic Patterns in Severe Asthma
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020


Molecular Markers of Telomere Dysfunction and Senescence are Common Findings in the Usual Interstitial Pneumonia Pattern of Lung Fibrosis
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018




Does a Tailored Intervention to Promote Adherence in Patients with Chronic Lung Disease Affect Exacerbations?
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019

Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease
Source: International Congress 2017 – COPD biomarkers
Year: 2017